BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18062917)

  • 1. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer.
    Vesuna F; van Diest P; Chen JH; Raman V
    Biochem Biophys Res Commun; 2008 Mar; 367(2):235-41. PubMed ID: 18062917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
    van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
    Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
    Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
    J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
    Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
    Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection.
    Sun T; Wang H; Li Q; Qian Z; Shen C
    Jpn J Clin Oncol; 2016 Mar; 46(3):209-21. PubMed ID: 26732382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
    Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
    PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of twist and E-cadherin in ovarian cancer tissues.
    Wang WS; Yu SL; Yang XS; Chang SD; Hou JQ
    Asian Pac J Cancer Prev; 2013; 14(2):669-72. PubMed ID: 23621216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
    Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
    Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of twist, E-cadherin, and N-cadherin in gastrointestinal stromal tumors.
    Ding J; Zhang Z; Pan Y; Liao G; Zeng L; Chen S
    Dig Dis Sci; 2012 Sep; 57(9):2318-24. PubMed ID: 22576709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
    Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
    Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
    Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma.
    Gao Y; Xuan XY; Zhang HY; Wang F; Zeng QR; Wang ZQ; Li SS
    Cell Biol Int; 2012 Jun; 36(6):571-7. PubMed ID: 22360285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
    Tan R; Wang L; Song J; Li J; He T
    J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities.
    Yang F; Sun L; Li Q; Han X; Lei L; Zhang H; Shang Y
    EMBO J; 2012 Jan; 31(1):110-23. PubMed ID: 21983900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells.
    Wang Q; Gun M; Hong XY
    Sci Rep; 2019 Oct; 9(1):14140. PubMed ID: 31578396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
    Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
    Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.